Stanford University: Insulin Resistance trials
The registry lists 33 Insulin Resistance studies with Stanford University as lead sponsor. 4 are open to participants now and 9 have results posted.
Early Phase 1 1Phase 1 5Phase 2 1Phase 4 3No phase 23(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or TirzepatideRecruitingNCT06657209Phase 4
- Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2RecruitingNCT05833217Not applicable
- Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin ResistanceRecruitingNCT05165706Not applicable
- Adaptive Immune Response in Visceral and Subcutaneous Fat: Role in Human Insulin ResistanceEnrolling by invitationNCT04708535
- Ertugliflozin: Cardioprotective Effects on Epicardial FatCompletedNCT04167761Early Phase 1Results posted
- Precision Diets for Diabetes PreventionCompletedNCT03919877Not applicableResults posted
- Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics ProfilingCompletedNCT02437084Phase 4Results posted
- A Patient-Centered Strategy for Improving Diabetes Prevention in Urban American IndiansCompletedNCT02266576Not applicableResults posted
- Obesity, Sleep Apnea, and Insulin ResistanceCompletedNCT02192684Not applicableResults posted
- Pioglitazone in Patients With Mood DisordersCompletedNCT01559857Phase 4Results posted
- Insulin Resistance in Pulmonary Arterial HypertensionTerminatedNCT00825266Phase 2Results posted
- Insulin Resistance in Patients With Mood DisorderCompletedNCT00242619Not applicableResults posted
- Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.CompletedNCT00186537Not applicableResults posted
- Subcutaneous Pharmacokinetic Evaluation of Monomeric Insulin and Lyumjev in Adults With Type 1 DiabetesCompletedNCT07090824Phase 1
- Early MRI Detection of Myocardial Deterioration as a Preventive, Disease Staging, and Prognostic Biomarker in Insulin ResistanceCompletedNCT03509441
- Chronic Cardiovascular Risk Outpatient Management in South Asians Using Digital Health TechnologyCompletedNCT03167996Not applicable
- Insulin Resistance and Accelerated Cognitive AgingCompletedNCT03039647
- Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With PrediabetesCompletedNCT02140983Phase 1
- Exenatide and Weight Loss for Diabetes PreventionCompletedNCT02084654Phase 1
- Adipose Tissue Response to Overfeeding in Insulin Resistance-Prone vs. Insulin Sensitive HumansCompletedNCT02084641Not applicable
- DIETFITS Study (Diet Intervention Examining the Factors Interacting With Treatment SuccessCompletedNCT01826591Not applicable
- Weight Loss Diet Study: Low Carb vs Low FatCompletedNCT01661426Not applicable
- Adiponectin Polymorphisms, Insulin Resistance, and Pharmacokinetics in ObesityCompletedNCT01593397Phase 1
- Effects of Glutathione (an Antioxidant) and N-Acetylcysteine on InflammationCompletedNCT01550432Not applicable
- Regional Fat Depots and Insulin ResistanceCompletedNCT01336777
- Effects of Omega-3 Fatty Acids on Markers of InflammationCompletedNCT01129050Not applicable
- Insulin Resistance in Patients With Major DepressionCompletedNCT01106313
- Defining the Role of Insulin Resistance in 'Idiopathic' Dilated CardiomyopathyTerminatedNCT00466713Not applicable
- Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2CompletedNCT00383604
- Side Effects of Antipsychotic MedicationsCompletedNCT00363181
- Integrating the Genetic and Metabolic Faces of ObesityCompletedNCT00285844Phase 1
- Correlation Between Continuous Glucose Monitoring and Intermittent Glucose Monitoring Values and Pregnancy OutcomesCompletedNCT00186004
- Treatment of Insulin Resistance in Hypertensive, Obese AdolescentsTerminatedNCT00185705Not applicable